Stocktoria
Shattuck Labs, Inc. STTK
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-10-09
Shattuck Labs, Inc. statistics & valuation
Market cap$582.0M
P / B7.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -5150.8% | -1408.3% | -5549.6% | -15848.0% | -150.8% |
| Net margin | -4880.9% | -1318.1% | -5268.4% | -15635.7% | -149.8% |
| FCF margin | -3995.3% | -1058.8% | -4926.7% | -16274.8% | -216.7% |
| Return on assets | -53.6% | -82.8% | -54.7% | -49.7% | -15.1% |
| Return on equity | -59.2% | -94.7% | -60.3% | -57.9% | -16.5% |
| Current ratio | 11.70 | 8.88 | 12.51 | 7.39 | 11.72 |
| Revenue growth | -82.5% | 245.3% | 154.1% | -97.8% | 202.2% |
Source: SEC EDGAR filings · CIK 0001680367 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.